APA引用形式

HATZIMICHAEL, E., LAGOS, K., VASSOU, A., GOUGOPOULOU, D., PAPOUDOU-BAI, A., & BRIASOULIS, E. (2016). Durable response to lenalidomide in a patient with myelodysplastic syndrome associated with isolated 5q deletion and JAK2 V617F mutation despite discontinuation of treatment. Mol Clin Oncol.

シカゴスタイル引用形

HATZIMICHAEL, ELEFTHERIA, KONSTANTINOS LAGOS, AMALIA VASSOU, DORA GOUGOPOULOU, ALEXANDRA PAPOUDOU-BAI, , EVANGELOS BRIASOULIS. "Durable Response to Lenalidomide in a Patient With Myelodysplastic Syndrome Associated With Isolated 5q Deletion and JAK2 V617F Mutation Despite Discontinuation of Treatment." Mol Clin Oncol 2016.

MLA引用形式

HATZIMICHAEL, ELEFTHERIA, et al. "Durable Response to Lenalidomide in a Patient With Myelodysplastic Syndrome Associated With Isolated 5q Deletion and JAK2 V617F Mutation Despite Discontinuation of Treatment." Mol Clin Oncol 2016.

警告: この引用は必ずしも正確ではありません.